RE:RE:RE:RE:RE:RE:RE:ADCOM lineRed:
I don't see us being around in 5 years. Ipsen buys us out ( friendly takeover) 6-18 months after approval. They are looking to move into our Bladder Cancer market.
When we get approval , we will be the media darling of the market , the little Canadian biotech that did it. Stock price will jump significantly and we get our listing on the Nasdaq a while later ( 2-3:1 stock split) . People will rush in because they will be looking to be on board a ground floor rising stock to recoup big loses they have received lately and will continue to receive as we go into recession ( if we're not already there yet ). Just great timing for once! JMHO
MCNA has multiple uses, Bladder,Breast and Prostate Cancer, chemo adjuvant ( white blood cells) and TURBT adjuvant .
Cheers
13PD